Asia-Pacific markets set to climb as Trump softens trade stance against China

Asia-Pacific markets set to climb as Trump softens trade stance against China


The Seoul skyline.

Mongkol Chuewong | Moment | Getty Images

Asia-Pacific markets were set to mostly climb Thursday, tracking gains on Wall Street as a possible thaw in U.S.-China trade war fuels investor optimism.

Japan’s benchmark Nikkei 225 was set to extend the previous day’s gains to open higher, with the futures contract in Chicago at 35,410 while its counterpart in Osaka last traded at 35,440, against the index’s last close of 34,868.63.

Australian markets were also set to open higher, with futures tied to the S&P/ASX 200 last seen at 7,946, compared to the index’s last close of 7,920.5

Futures for Hong Kong’s Hang Seng index stood at 22,069, little changed from HSI’s last close of 22,072.62.

South Korea’s GDP contracted 0.1% in the first quarter of 2025, according to advance figures released Thursday, missing the 0.1% rise expected by a Reuters poll.

U.S. futures were subdued after the major U.S. indexes posted a second straight winning day. S&P 500 futures were up 0.1%, while Nasdaq 100 futures traded nearly 0.1% higher. Futures tied to the Dow Jones Industrial Average lost 45 points, or 0.1%.

Overnight stateside, the three major averages closed higher on hopes that U.S.-China trade tensions could soon ease. President Donald Trump also signaled he does not plan to remove Federal Reserve Chair Jerome Powell from his post as central bank leader.

The Dow Jones Industrial Average added 419.59 points, or 1.07%, to close at 39,606.57. The S&P 500 climbed 1.67% to end at 5,375.86, and the Nasdaq Composite rallied 2.50% to settle at 16,708.05. All three indexes posted back-to-back gains.

— CNBC’s Lisa Kailai Han and Brian Evans contributed to this report.



Source

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More
Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead
World

Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead

European stocks are expected to open lower, mirroring global declines as concerns grow over sky-high tech valuations. Source

Read More
California voters approve new U.S. House map to boost Democrats in 2026
World

California voters approve new U.S. House map to boost Democrats in 2026

California voters approved new congressional district boundaries Tuesday, delivering a victory for Democrats in the state-by-state redistricting battle that will help determine which party wins control of the U.S. House in 2026 and, with it, the power to thwart or advance President Donald Trump’s agenda. The approval of Proposition 50 gives Democrats a shot at […]

Read More